Ac225-DOTA-M5A / National Cancer Institute - Bethesda, City of Hope  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ac225-DOTA-M5A / City of Hope, National Cancer Institute - Bethesda
NCT05204147: Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

Recruiting
1
20
US
Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A, 225Ac-DOTA-anti-CEA Monoclonal Antibody M5A, 225Ac-DOTA-M5A Humanized Anti-CEA Antibody, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected
City of Hope Medical Center, National Cancer Institute (NCI)
Advanced Cancer, Metastatic Cancer
08/25
08/25

Download Options